Cargando…
A Combined Treatment with Berberine and Andrographis Exhibits Enhanced Anti-Cancer Activity through Suppression of DNA Replication in Colorectal Cancer
The high morbidity and mortality associated with colorectal cancer (CRC) are largely due to the invariable development of chemoresistance to classic chemotherapies, as well as intolerance to their significant toxicity. Many pharmaceutical formulations screened from natural plant extracts offer safe,...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953248/ https://www.ncbi.nlm.nih.gov/pubmed/35337060 http://dx.doi.org/10.3390/ph15030262 |
_version_ | 1784675802702413824 |
---|---|
author | Zhao, Yinghui Roy, Souvick Wang, Chuanxin Goel, Ajay |
author_facet | Zhao, Yinghui Roy, Souvick Wang, Chuanxin Goel, Ajay |
author_sort | Zhao, Yinghui |
collection | PubMed |
description | The high morbidity and mortality associated with colorectal cancer (CRC) are largely due to the invariable development of chemoresistance to classic chemotherapies, as well as intolerance to their significant toxicity. Many pharmaceutical formulations screened from natural plant extracts offer safe, inexpensive, and multi-target therapeutic options. In this study, we demonstrated that Berberis vulgaris L. (Berberine) and Andrographis paniculata (Burm. f.) Nees (Andrographis) extracts exerted their synergistic amplified anti-cancer effects by jointly inhibiting cell viability, suppressing colony formation, and inducing cell cycle arrest. Consistent with our in-vitro findings, the amplified synergistic anti-cancer effects were also observed in subcutaneous xenograft preclinical animal models, as well as patient-derived primary tumor organoids. To explore the molecular mechanisms underlying the amplified synergistic anti-cancer effects, RNA sequencing was performed to identify candidate pathways and genes. A transcriptome analysis revealed that DNA-replication-related genes, including FEN1, MCM7, PRIM1, MCM5, POLA1, MCM4, and PCNA, may be responsible for the enhanced anticancer effects of these two natural extracts. Taken together, our data revealed the powerful enhanced synergistic anti-CRC effects of berberine and Andrographis and provide evidence for the combinational targeting of DNA-replication-related genes as a promising new strategy for the therapeutic option in the management of CRC patients. |
format | Online Article Text |
id | pubmed-8953248 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89532482022-03-26 A Combined Treatment with Berberine and Andrographis Exhibits Enhanced Anti-Cancer Activity through Suppression of DNA Replication in Colorectal Cancer Zhao, Yinghui Roy, Souvick Wang, Chuanxin Goel, Ajay Pharmaceuticals (Basel) Article The high morbidity and mortality associated with colorectal cancer (CRC) are largely due to the invariable development of chemoresistance to classic chemotherapies, as well as intolerance to their significant toxicity. Many pharmaceutical formulations screened from natural plant extracts offer safe, inexpensive, and multi-target therapeutic options. In this study, we demonstrated that Berberis vulgaris L. (Berberine) and Andrographis paniculata (Burm. f.) Nees (Andrographis) extracts exerted their synergistic amplified anti-cancer effects by jointly inhibiting cell viability, suppressing colony formation, and inducing cell cycle arrest. Consistent with our in-vitro findings, the amplified synergistic anti-cancer effects were also observed in subcutaneous xenograft preclinical animal models, as well as patient-derived primary tumor organoids. To explore the molecular mechanisms underlying the amplified synergistic anti-cancer effects, RNA sequencing was performed to identify candidate pathways and genes. A transcriptome analysis revealed that DNA-replication-related genes, including FEN1, MCM7, PRIM1, MCM5, POLA1, MCM4, and PCNA, may be responsible for the enhanced anticancer effects of these two natural extracts. Taken together, our data revealed the powerful enhanced synergistic anti-CRC effects of berberine and Andrographis and provide evidence for the combinational targeting of DNA-replication-related genes as a promising new strategy for the therapeutic option in the management of CRC patients. MDPI 2022-02-22 /pmc/articles/PMC8953248/ /pubmed/35337060 http://dx.doi.org/10.3390/ph15030262 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Zhao, Yinghui Roy, Souvick Wang, Chuanxin Goel, Ajay A Combined Treatment with Berberine and Andrographis Exhibits Enhanced Anti-Cancer Activity through Suppression of DNA Replication in Colorectal Cancer |
title | A Combined Treatment with Berberine and Andrographis Exhibits Enhanced Anti-Cancer Activity through Suppression of DNA Replication in Colorectal Cancer |
title_full | A Combined Treatment with Berberine and Andrographis Exhibits Enhanced Anti-Cancer Activity through Suppression of DNA Replication in Colorectal Cancer |
title_fullStr | A Combined Treatment with Berberine and Andrographis Exhibits Enhanced Anti-Cancer Activity through Suppression of DNA Replication in Colorectal Cancer |
title_full_unstemmed | A Combined Treatment with Berberine and Andrographis Exhibits Enhanced Anti-Cancer Activity through Suppression of DNA Replication in Colorectal Cancer |
title_short | A Combined Treatment with Berberine and Andrographis Exhibits Enhanced Anti-Cancer Activity through Suppression of DNA Replication in Colorectal Cancer |
title_sort | combined treatment with berberine and andrographis exhibits enhanced anti-cancer activity through suppression of dna replication in colorectal cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953248/ https://www.ncbi.nlm.nih.gov/pubmed/35337060 http://dx.doi.org/10.3390/ph15030262 |
work_keys_str_mv | AT zhaoyinghui acombinedtreatmentwithberberineandandrographisexhibitsenhancedanticanceractivitythroughsuppressionofdnareplicationincolorectalcancer AT roysouvick acombinedtreatmentwithberberineandandrographisexhibitsenhancedanticanceractivitythroughsuppressionofdnareplicationincolorectalcancer AT wangchuanxin acombinedtreatmentwithberberineandandrographisexhibitsenhancedanticanceractivitythroughsuppressionofdnareplicationincolorectalcancer AT goelajay acombinedtreatmentwithberberineandandrographisexhibitsenhancedanticanceractivitythroughsuppressionofdnareplicationincolorectalcancer AT zhaoyinghui combinedtreatmentwithberberineandandrographisexhibitsenhancedanticanceractivitythroughsuppressionofdnareplicationincolorectalcancer AT roysouvick combinedtreatmentwithberberineandandrographisexhibitsenhancedanticanceractivitythroughsuppressionofdnareplicationincolorectalcancer AT wangchuanxin combinedtreatmentwithberberineandandrographisexhibitsenhancedanticanceractivitythroughsuppressionofdnareplicationincolorectalcancer AT goelajay combinedtreatmentwithberberineandandrographisexhibitsenhancedanticanceractivitythroughsuppressionofdnareplicationincolorectalcancer |